Steroid Use May Blunt Anti-PD-1 Effect in NSCLC

(MedPage Today) -- Lower response rate, PFS, survival with ?10 mg/day baseline dose
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news